The purpose of the Drug Origin Transparency Act of 2026 is to improve the reporting and labeling of drug manufacturing information. This legislation aims to enhance transparency in the pharmaceutical supply chain, ensuring that consumers and healthcare providers have better access to information about the origins of drugs and their ingredients. Key provisions of the Act include requirements for drug manufacturers to report detailed information about their supply chains.